Pfizer to settle Bextra, Celebrex claims for $894M
Pharma Compliance Alert, October 22, 2008
Pfizer has agreed in principle to pay $894 million to settle all lawsuits related to its non-steroidal anti-inflammatory drugs Bextra and Celebrex, according to a company release.
The settlement covers more than 90% of the personal injury lawsuits filed by patients who claim the drugs caused a heart attack, stroke, or other injury. The settlement also resolves payer class action consumer fraud cases involving Bextra and Celebrex in which plaintiffs allege economic loss relating to the promotion of these medications.
Comments
3 comments on “Pfizer to settle Bextra, Celebrex claims for $894M ”
- Linda Shelton (6/1/2009 at 3:11 PM)
- I also would like more information on the lawsuit. I was diagnosed in May of 1998 with fibromyalgia, bi-lateral carpal tunnel syndrome and bi-lateral thoracic outlet syndrome. Celebrex was prescribed for pain relief but even with insurance co-pay, the product was too expensive to use. Please send more info on the lawsuit. Thank you.
Related Products
-
Healthcare Life Safety Compliance
Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.
-
Briefings on Infection Control
Your facility's infection control and prevention initiatives are in the spotlight: Scrutiny from The Joint Commission, CDC...
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Medical Environment Update
Timely medical compliance news from OSHA, CDC, EPA, and other regulatory agencies!
-
OSHA Regulatory Manual for Healthcare
The OSHA Regulatory Manual for Healthcare is packed with clear, concise tips, tools, and strategies that are designed to...
Most Popular
- Articles
-
- Q/A: May we bill an E/M code for a wound care first visit
- Peer Review Monthly: Do you know what I know?
- 2010 ICD-9 code updates now available online
- Omnicare to pay $98 million to settle kickback charges
- Eliminate missed charges, errors to reduce lost revenue
- New, more deadly strain of MRSA found
- Study: Action can be taken to reduce dementia risk
- Understand the H1N1 Flu and how to code it
- Texas Hospital group pays U.S. $27.5 million in false claims settlement
- Tamiflu ® shortage sparks dosing confusion at some facilities
- E-mailed
-
- Q/A: May we bill an E/M code for a wound care first visit
- Omnicare to pay $98 million to settle kickback charges
- New, more deadly strain of MRSA found
- Peer Review Monthly: Do you know what I know?
- Eliminate missed charges, errors to reduce lost revenue
- Medicare patients suffer from a medical error every 1.7 minutes
- QA:Coding multiple initial infusions
- Study: Action can be taken to reduce dementia risk
- First board certification for hospitalists announced -- with caution
- Experts: Hospitals not the place for personal e-mail, social networking sites
- Searched